Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

22 sedative hypnotic drugs

6,796 views

Published on

Published in: Education, Health & Medicine
  • Login to see the comments

22 sedative hypnotic drugs

  1. 1. SEDATIVE-HYPNOTIC DRUGS Anita Q. Sangalang, MD, FPOGS FACULTY OF PHARMACY UNIVERSITY OF SANTO TOMAS
  2. 2. SEDATIVE-HYPNOTIC DRUGS SEDATIVE-HYPNOTICS Benzodiazepines Barbiturates Miscellaneous agents Short Ultra action action Intermediate Short Buspirone action action Chloral hydrate Long Long Zaleplon action action Zolpidem
  3. 3. SEDATIVE-HYPNOTIC DRUGS SEDATION • Reduction of anxiety • Calming effect ANXIOLYTIC • Drug that reduces anxiety • Sedative HYPNOSIS • Induction of sleep
  4. 4. SEDATIVE-HYPNOTIC DRUGS • Lipid soluble • Absorbed well from the GIT • Good distribution to the brain • Metabolized before elimination from the body by hepatic enzymes
  5. 5. SEDATIVE-HYPNOTIC DRUGS BENZODIAZEPINES • Converted initially to active metabolites with long half-lives • Diazepam and flurazepam  After several days of therapy accumulation of active metabolites can lead to excessive sedation
  6. 6. SEDATIVE-HYPNOTIC DRUGS BENZODIAZEPINES • Lorazepam and oxazepam  Undergo extrahepatic conjugation and do not form active metabolites
  7. 7. SEDATIVE-HYPNOTIC DRUGS BENZODIAZEPINES • Bz receptors  Form part of GABAA receptor-chloride ion channel macromolecular structure  Binding facilitates the inhibitory actions of GABA  Increased GABA mediated chloride ion conductance
  8. 8. SEDATIVE-HYPNOTIC DRUGS BENZODIAZEPINES • Flumazenil  Reverses the CNS effects of benzodiazepines  Antagonist at the Bz receptor
  9. 9. SEDATIVE-HYPNOTIC DRUGS BENZODIAZEPINES • Beta-carbolines  High affinity for Bz receptors  Can elicit anxiogenic and convulsant effects  Inverse agonists
  10. 10. SEDATIVE-HYPNOTIC DRUGS BENZODIAZEPINES • Diazepam desmathyldiazepam active oxazepam metabolites conjugation
  11. 11. SEDATIVE-HYPNOTIC DRUGS BENZODIAZEPINES • Chlorazepam • Estazolam immediately converted to • Oxazepam inactive metabolites
  12. 12. SEDATIVE-HYPNOTIC DRUGS BARBITURATES • Extensively metabolized • Depress the neuronal activity • Facilitates and prolongs the inhibitory effects of GABA and glycine
  13. 13. SEDATIVE-HYPNOTIC DRUGS BARBITURATES • Bind to multiple isoforms of GABAA receptor but at different sites from those with which benzodiazepines interact
  14. 14. SEDATIVE-HYPNOTIC DRUGS BARBITURATES • Not antagonize by flumazenil • Increase the duration of GABA- mediated chloride ion channel opening
  15. 15. SEDATIVE-HYPNOTIC DRUGS BARBITURATES • Block the excitatory transmitter glutamic acid and at high concentration, sodium channels
  16. 16. SEDATIVE-HYPNOTIC DRUGS BARBITURATES • Thiopental  Drug with highest lipid solubility enter the CNS rapidly  Used as induction agents in anesthesia
  17. 17. SEDATIVE-HYPNOTIC DRUGS BARBITURATES • Thiopental  CNS effects are terminated by rapid redistribution of the drug from the brain to other highly perfused tissues (skeletal muscles)
  18. 18. SEDATIVE-HYPNOTIC DRUGS BARBITURATES • Thiopental  Metabolism occur via oxidation and glucoronidation  Converted to active metabolite
  19. 19. SEDATIVE-HYPNOTIC DRUGS BARBITURATES • Phenobarbital  Goes to the liver to be oxidized  Excreted partly unchanged in the urine  Alkalinizes the urine  Half-life of 4-5 days  Requires loading dose
  20. 20. SEDATIVE-HYPNOTIC DRUGS OTHER DRUGS • Buspirone  Partial agonist at serotonin receptor (5-HT receptor)  Impairment of mental activity  Psychomotor impairment  Selective with minimal depressant effects on the CNS
  21. 21. SEDATIVE-HYPNOTIC DRUGS OTHER DRUGS • Zolpidem and zaleplon  Exert their CNS effects via interaction with benzodiazepine receptors  Bind more selectively  Antagonize by flumazenil
  22. 22. SEDATIVE-HYPNOTIC DRUGS DRUG A - BARBITURATES dose = CNS depression DRUG B - BENZODIAZEPINES - flatter dose response curve - greater margin of safety DRUG A DRUG B
  23. 23. SEDATIVE-HYPNOTIC DRUGS ORGAN SYSTEM EFFECTS 1. Sedation 2. Hypnosis • Promote sleep onset • Increase the duration of the sleep state STAGES OF SLEEP a. REM (Rapid eye movement) • Dream • Decreases at high doses b. Non-REM • 70-75%
  24. 24. SEDATIVE-HYPNOTIC DRUGS ORGAN SYSTEM EFFECTS 3. Anesthesia • Thiopental (barbiturate) • Midazolam (benzodiazepine) • Loss of consciousness, amnesia and suppression of reflexes
  25. 25. SEDATIVE-HYPNOTIC DRUGS ORGAN SYSTEM EFFECTS 4. Anticonvulsant actions • Phenobarbital, clonazepam  Suppression of seizure activity  Selective because they do not cause severe sedation
  26. 26. SEDATIVE-HYPNOTIC DRUGS ORGAN SYSTEM EFFECTS 4. Anticonvulsant actions • Diazepam, lorazepam and phenobarbital  Given IV  Used in status epilepticus  Heavy sedation is needed
  27. 27. SEDATIVE-HYPNOTIC DRUGS ORGAN SYSTEM EFFECTS 5. Muscle relaxation • Diazepam  Spasticity states  Cerebral palsy
  28. 28. SEDATIVE-HYPNOTIC DRUGS ORGAN SYSTEM EFFECTS 6. Medullary depression • High doses can lead to  Respiratory arrest  Hypotension  CVS collapse  Death in suicidal overdose
  29. 29. SEDATIVE-HYPNOTIC DRUGS ORGAN SYSTEM EFFECTS 7. Tolerance and dependence • Tolerance  Decrease in responsiveness  Used chronically or in high dosage
  30. 30. SEDATIVE-HYPNOTIC DRUGS ORGAN SYSTEM EFFECTS 7. Tolerance and dependence • Tolerance  Metabolic tolerance  Occurs with phenobarbital  Induces its own metabolism  Decreases CNS response to the drug itself
  31. 31. SEDATIVE-HYPNOTIC DRUGS ORGAN SYSTEM EFFECTS 7. Tolerance and dependence • Dependence Physiologic  State of response to a drug  Removal of the drug evokes unpleasant symptoms  Opposite of the drug’s effects
  32. 32. SEDATIVE-HYPNOTIC DRUGS ORGAN SYSTEM EFFECTS 7. Tolerance and dependence • Dependence Physiologic  Leads to abstinence syndrome (withdrawal state) when the drug is discontinued
  33. 33. SEDATIVE-HYPNOTIC DRUGS ORGAN –SYSTEM EFFECTS 7. Tolerance and dependence • Dependence Physiologic  Withdrawal signs  Anxiety  Tremors  Hyperreflexia  Seizures
  34. 34. SEDATIVE-HYPNOTIC DRUGS ORGAN SYSTEM EFFECTS 7. Tolerance and dependence • Dependence Physiologic  Occur more commonly with short- acting drugs  Pentobarbital and secobarbital  Dependence is unlikely to occur with buspirone
  35. 35. SEDATIVE-HYPNOTIC DRUGS ORGAN SYSTEM EFFECTS 7. Tolerance and dependence • Dependence Psychological  State of response to a drug  Drug taker feels compelled to use the drug  Suffers anxiety when separated from the drug
  36. 36. SEDATIVE-HYPNOTIC DRUGS CLINICAL USES 1. Anxiety states • Benzodiazepines with intermediate or long durations of action are favored • Buspirone  Used for generalized anxiety disorders • Alprazolam  Phobic and panic attacks
  37. 37. SEDATIVE-HYPNOTIC DRUGS CLINICAL USES 2. Sleep disorders • Used to treat primary insomnia and other sleep disorders
  38. 38. SEDATIVE-HYPNOTIC DRUGS CLINICAL USES 3. Sedation • Prior to medical/surgical procedures • Conscious sedation-anterograde amnesia 4. Treatment of seizures and convulsions
  39. 39. SEDATIVE-HYPNOTIC DRUGS CLINICAL USES 4. Detoxification of alcoholics • Chlordiazepoxide • Diazepam 6. Muscle relaxation 7. Manias, major depression, phobias
  40. 40. SEDATIVE-HYPNOTIC DRUGS TOXICITY 1. Psychomotor dysfunction • Cognitive impairment • Decreased psychomotor skills • Unwanted daytime sedation
  41. 41. SEDATIVE-HYPNOTIC DRUGS TOXICITY 2. Additive CNS depression • When used with  Alcoholic beverages  Antihistamines  Antipsychotic drugs  Opioid analgesics  Tricyclic antidepressants
  42. 42. SEDATIVE-HYPNOTIC DRUGS TOXICITY 3. Overdosage causes severe respiratory and cardiovascular depression 4. Terratogenic
  43. 43. SEDATIVE-HYPNOTIC DRUGS TOXICITY 3. Induce formation of liver microsomal enzymes • Metabolize drugs multiple drug interactions • Chloral hydrate displaces coumarin from protein binding sites and increases anticoagulant effects

×